NPPA computed the Retail Price of 5 ml suspension contains: Bilastine IP 10 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg Suspension for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Hetero Healthcare Ltd. (Marketer)

Feb 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Compliance

The National Pharmaceutical Pricing Authority (NPPA) on February 12, 2026, issued the Computation of Retail Price of 5 ml suspension contains: Bilastine IP 10 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg Suspension for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Hetero Healthcare Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from July 2025

• The Retail Price has been computed for Each Film Coated Tablet Containing 5 ml suspension contains: Bilastine IP 10 mg + Montelukast Sodium IP Eq. to Montelukast 4 mg Suspension for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Hetero Healthcare Ltd. (Marketer)

• The Proposed Retail Price is 1.75 Excluding GST


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT